Ligand profile
ZINC72481992
Virtual-screening candidate from ZINC.
Bound to: KP13_01911 — Peptidoglycan synthase ftsI
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC72481992- UniProt (similar protein)
G3XD46- Tanimoto
- 0.553
- Target protein
- KP13_01911
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 81.4
- −1 ≤ LogP ≤ 5 1.33
- MW ≤ 500 Da 228.3
- LogP ≤ 5 1.33
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 81.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C=C[C@@](C)(CC(N)=O)NC(=O)OC(C)(C)CC=C[C@@](C)(CC(N)=O)NC(=O)OC(C)(C)C
InChI=1S/C11H20N2O3/c1-6-11(5,7-8(12)14)13-9(15)16-10(2,3)4/h6H,1,7H2,2-5H3,(H2,12,14)(H,13,15)/t11-/m0/s1InChI=1S/C11H20N2O3/c1-6-11(5,7-8(12)14)13-9(15)16-10(2,3)4/h6H,1,7H2,2-5H3,(H2,12,14)(H,13,15)/t11-/m0/s1
YNIXWVYBPKULAR-NSHDSACASA-NYNIXWVYBPKULAR-NSHDSACASA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- OEE
- Homolog
- G3XD46
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC72481992 →
- ZINC ZINC20 ZINC72481992 →
- UniProt UniProt G3XD46 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC72481992”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01911.
PDB 25
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).